NEW HAVEN  Conn and FLORENCE  Italy  March 1  2017 – Melinta Therapeutics  a privately held company developing novel antibiotics to treat serious bacterial infections  and Menarini Group  an Italian biopharmaceutical group  today announced the signing of a development and commercialization agreement